FibroBiologics, Inc. (NasdaqCM: FBLG)
Health Care · Biotechnology · US
$0.97
-14.07% today · -88.2% 1Y
FibroBiologics, Inc. (NasdaqCM: FBLG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.75M and employs 15 people.
Over the last twelve months the share price has lost 88.2%, trading between 0.62 and 9.60.
Tweenvest scores FibroBiologics, Inc. across four factors: quality 34/100, value 29/100. Its strongest factor is quality.
FBLG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.75M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.77
- Dividend yield
- —
- Beta (5Y)
- 1.74
- 52-week high
- $9.60
- 52-week low
- $0.62
- Avg volume (3M)
- —
- Shares outstanding
- 6.96M
- Employees
- 15
- Next earnings
- —
About FibroBiologics, Inc.
FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.
- ISIN
- US31573L2043
- Founded
- 2021
- Listed since
- Feb 1, 2024
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $7.00M | $0.22 | -28.47% |
| Rakovina Therapeutics Inc.TSXV: RKV | $6.93M | CA$0.22 | -2.22% |
| Skye Bioscience, Inc.NasdaqCM: SKYE | $6.86M | $1.55 | -8.28% |
| CollPlant Biotechnologies Ltd.NasdaqCM: CLGN | $6.85M | $3.63 | +3.28% |
| Alaunos Therapeutics, Inc.NasdaqCM: TCRT | $6.68M | $2.63 | +234.69% |
| Arctic Bioscience ASOB: ABS | $6.59M | Nkr2.31 | -12.50% |
| VitaSpring Biomedical Co. Ltd.OTCPK: VSBC | $6.58M | $0.03 | — |
| AcouSort AB (publ)OM: ACOU | $6.54M | Skr3.06 | +2.00% |
Figures last refreshed Oct 18, 2026.